Search for: "ALTERNATIVE BRANDS, INC." Results 541 - 560 of 908
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2013, 5:25 pm by Cicely Wilson
” A reviewing court must ultimately be satisfied that no workable race-neutral alternative would produce the educational benefits of diversity. [read post]
24 Jun 2013, 12:50 pm by Bexis
  “[T]he FDCA requires a generic drug to have the same active ingredients, route of administration, dosage form, strength, and labeling as the brand-name drug on which it is based. [read post]
18 Jun 2013, 9:18 am by Rebecca Tushnet
Barbara's Bakery, Inc., --- F.Supp.2d ----, 2013 WL 2948154 (E.D.N.Y.) [read post]
17 Jun 2013, 1:03 pm by David Kemp
Actavis, Inc., United States Supreme Court (6/17/13)Antitrust & Trade Regulation, Drugs & BiotechThe Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Act), 21 U.S.C. 355(j)(2)(A)(vii)(IV) established procedures for identifying and resolving patent disputes between brand-name and generic drug manufacturers. [read post]
10 Jun 2013, 9:30 pm by Alix McKenna
Watson Pharmaceuticals, Inc, a case raising the question of the legality of these agreements. [read post]
6 Jun 2013, 12:15 am
The doctrine of inherent anticipation (particularly after Schering Co. v Geneva Pharmaceuticals Inc. et Al., commented here - see also, in the UK, Merrell Dow v H N Norton & Co), may lead to similar distortions. [read post]
12 May 2013, 5:54 pm by Omar Ha-Redeye
Last fall the Circuit Court of Virginia rule in Hadeed Carpet Cleaning, Inc. v. [read post]
21 Apr 2013, 9:45 am by John W. Arden
Under the proposed final judgment, the companies would be required to divest Modelo's entire U.S. business to Constellation Brands Inc. or to an alternative purchaser if for some reason the transaction with Constellation cannot be completed. [read post]
19 Apr 2013, 9:00 am by P. Andrew Torrez
Next:  Medical company Kinetic Concepts, Inc. [read post]
3 Apr 2013, 6:52 am by Bill Marler
  That same day the FDA issued an alert to warn consumers not to eat Veggie Booty Snack Food and to discard any Robert’s American Gourmet brand Veggie Booty. [read post]
22 Mar 2013, 10:36 am by Bexis
Medtronic, Inc., 552 U.S. 312, 337 n.7 (2008) (dissent; also referencing “traditional common-law remedies”).Not so in Bartlett. [read post]
13 Mar 2013, 1:55 pm by Brett Frischmann
Watson Pharmaceuticals, Inc., a case concerning reverse payment settlements of patent litigation. [read post]
13 Mar 2013, 4:45 am by Federal Trade Commission
Related posts:FTC Submits Amicus Brief Explaining that Drug Companies Use “No-Authorized Generic” Agreements to Delay Generic CompetitionIn a “no-AG” agreement, the branded firm, as part of the patent litigation settlement, agrees that it will not launch its own generic alternative when the first generic begins to compete. [read post]
12 Mar 2013, 6:40 am by Dennis Crouch
Watson Pharmaceuticals, Inc., a case concerning reverse payment settlements of patent litigation. [read post]